Fierce Pharma4h
FDA chief counsel Hilary Perkins hits the exit, resigning amid controversy two days into the job
Just two days after starting at the FDA, the agency’s Chief Counsel Hilary Perkins is signing off, effective immediately. | ...
KRRO-110 Receives Orphan Drug Designation from U.S. FDA for Alpha-1 Antitrypsin Deficiency
KRRO-110 is the first RNA editing development candidate from Korro’s proprietary OPERA TM platform and is currently being evaluated in the Phase 1/2a REWRITE clinical study for AATD. Dosing of the ...
US FDA's top lawyer Hilary Perkins resigns two days into role
The U.S. Food and Drug Administration's chief counsel, Hilary Perkins, has resigned, the federal agency said in a post on ...
Ex-Twitter AI ethics lead Rumman Chowdhury is worried about Musk’s impact on the federal government
Rumman Chowdhury, ex-director of Twitter's machine ethics team, has strong words for Elon Musk and the Department of ...
American Hospital Association23h
White House withdraws nomination for CDC director; Senate committee advances NIH, FDA picks
The White House March 13 withdrew the nomination of former Republican congressman Dave Weldon for director of the Centers for ...
FDA top lawyer resigns days after starting job
The U.S. Food and Drug Administration’s (FDA) chief counsel resigned two days after her appointment, according to a Thursday announcement from the agency. “Hilary K. Perkins has ...
RFK Jr.’s first month as health secretary: Touting French fries and casting doubts on vaccines
Kennedy vowed to “Make America Healthy Again,” has delivered an inconsistent message that has the nation’s top infectious ...
Trump’s FDA and NIH picks clear committee, teeing up final Senate confirmation
The Senate Health, Education, Labor, and Pensions Committee approved Dr. Jayanta Bhattacharya’s nomination to be NIH director ...
Companies warn investors that DOGE’s federal cuts might hurt business
As earnings season begins, filings to the SEC point to uncertainty from the current administration as potential trouble for ...
BioSpace7d
FDA Weathers Bait-and-Switch Storm as Staff and Sites Come and Go
Marty Makary, likely FDA commissioner under President Trump, appeared before Congress this week as the agency he’s set to lead continues to be rocked by sweeping changes and about-faces.
Philadelphia Tribune15d
FDA meeting to choose flu vaccine composition canceled without explanation
A March meeting of outside advisers to the US Food and Drug Administration to discuss the composition of flu vaccines for this fall’s flu season has been canceled, a member of the advisory ...
Penn Live15d
FDA cancels flu vaccine meeting and now health experts are worried
A Food and Drug Administration (FDA) meeting that was scheduled to discuss next season’s flu vaccines has been canceled, leaving some experts to worry that the flu vaccine delivery schedule will ...